Group 1 - Madison Square Garden (MSGS) reported revenue of $203.96 million for the quarter ended June 2025, a decrease of 10.3% year-over-year, with an EPS of -$0.07 compared to $1.06 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $165.69 million by 23.1%, and the EPS surprised by 83.33% against the consensus estimate of -$0.42 [1] - The stock has returned -4.3% over the past month, underperforming the Zacks S&P 500 composite's +3.1% change, and currently holds a Zacks Rank 5 (Strong Sell) [3] Group 2 - Total revenues from event-related contracts were $140.32 million, surpassing the average estimate of $88.37 million, but reflecting a year-over-year decline of 7.8% [4] - League distributions and other revenues totaled $3.99 million, below the average estimate of $5.08 million, marking a significant year-over-year decrease of 66.8% [4] - Sponsorship, signage, and suite licenses generated $31.88 million, slightly above the estimated $29.22 million, but down 8.2% compared to the previous year [4] - Media rights revenues were reported at $27.77 million, slightly below the estimated $28.38 million, with a year-over-year decline of 2.3% [4]

Brinker International, Inc. EAT will release earnings results for the fourth quarter before the opening bell on Wednesday, Aug. 13. Analysts expect the Dallas, Texas-based company to report quarterly earnings at $2.47 per share, versus $1.61 per share in the year-ago period. Brinker International projects to report quarterly revenue of $1.44 billion, compared to $1.21 billion a year earlier, according to data from Benzinga Pro. Benzinga readers can access the latest analyst ratings on the Analyst Stock Rati ...

Core Insights - Cardinal Health, Inc. reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of $2.08, exceeding the Zacks Consensus Estimate of $2.03 by 2.5% and reflecting a 13% year-over-year improvement [1] - The company raised its fiscal 2026 earnings guidance, anticipating adjusted EPS between $9.30 and $9.50, up from a previous outlook of $9.10-$9.30 [9] Revenue Details - Total sales for the quarter were flat year-over-year at $60.2 billion, missing the Zacks Consensus Estimate by 0.8% [2] Segmental Analysis - **Pharmaceutical and Specialty Solutions**: Revenues were nearly flat at $55.4 billion year-over-year, but excluding the impact of a customer contract expiration, sales increased by 22% [3] - **Pharmaceutical Profit**: Totaled $535 million, an 11% increase from the previous year, driven by growth in brand and specialty products [4] - **Global Medical Products and Distribution**: Revenues reached $3.2 billion, up 3% year-over-year, with profits increasing from $47 million to $70 million [4] - **Other Segment**: Sales grew by 37% year-over-year to $1.6 billion, with profits rising 44% to $160 million [5] Margin Analysis - Gross profit increased by 17% year-over-year to $2.2 billion, with a gross margin of 3.7%, expanding approximately 50 basis points [6] Financial Update - The company ended the quarter with cash and cash equivalents of $3.33 billion, down from $3.81 billion in the previous quarter, while net cash provided by operating activities was $2.91 billion compared to a net cash usage of $27 million in the prior year [8] 2026 Outlook - The company expects revenues from the Pharmaceutical segment to grow by 11-13% year-over-year, with segmental profit also anticipated to increase by 11-13% [9] - Medical segment revenues are estimated to grow by 2-4%, while the Other segment is projected to see revenue growth of 26-28% [10] Conclusion - Cardinal Health's fourth-quarter results showed mixed performance, with earnings exceeding estimates but revenues falling short. Profit growth was observed across all segments, particularly in Pharmaceutical and Specialty Solutions, Global Medical Products, and the Other segment [11]

Core Insights - ANI Pharmaceuticals reported $211.37 million in revenue for Q2 2025, a 53.1% year-over-year increase, with an EPS of $1.80 compared to $1.02 a year ago, exceeding Zacks Consensus Estimates [1] - The company achieved a revenue surprise of +12.22% and an EPS surprise of +30.43% compared to analyst expectations [1] Revenue Breakdown - Net Revenues from Rare Disease and Brands - Cortrophin Gel: $81.65 million, surpassing the estimated $65.23 million [4] - Net Revenues from Rare Disease and Brands - ILUVIEN and YUTIQ: $22.32 million, slightly above the $21.74 million estimate [4] - Net Revenues from Generic pharmaceutical products: $90.3 million, exceeding the $85.32 million estimate [4] - Total Net Revenues from Rare Disease: $103.96 million, compared to the estimated $86.96 million [4] - Total Net Revenues from Generics and Other: $94.21 million, slightly below the $96.49 million estimate [4] - Net Revenues from Royalties and other pharmaceutical services: $3.92 million, significantly below the estimated $10.46 million [4] - Total Net Revenues from Rare Disease and Brands: $117.16 million, far exceeding the estimated $94.3 million, representing a year-over-year change of +138.2% [4] Stock Performance - ANI's shares have returned +25.4% over the past month, outperforming the Zacks S&P 500 composite's +2.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3]

Core Viewpoint - Chime Financial's stock experienced a significant drop following a strong earnings report, as investors took profits after a substantial increase post-IPO [1][2]. Financial Performance - In Q2, Chime reported a revenue increase of 37% to $528 million, with payments revenue growing by 19% and platform-related revenue soaring by 113% [3]. - The company recorded a net loss of $923 million, primarily due to a one-time stock-based compensation expense from its IPO; without this, Chime would have reported a profit of $5 million and an adjusted EBITDA of $16 million [4]. - Management provided a full-year revenue forecast for 2025 between $2.135 billion and $2.155 billion, along with adjusted EBITDA expectations of $84 million to $94 million, surpassing analyst estimates [5]. Market Reaction - Despite strong earnings, the stock's valuation remains high, trading at 5 times this year's revenue guidance and over 110 times this year's EBITDA guidance, indicating that while not excessively valued for a high-growth company, it is not considered cheap either [7]. - The earnings report is viewed as a strong start to Chime's public life, but the company will need to continue demonstrating its growth potential to maintain investor confidence [8].

Core Insights - Akamai Technologies, Inc. (AKAM) reported strong second-quarter 2025 results, with both revenue and net income exceeding the Zacks Consensus Estimate [1][2] Financial Performance - GAAP net income decreased to $103.6 million or 71 cents per share from $131.7 million or 86 cents per share year-over-year, impacted by high operating expenses [2] - Non-GAAP net income increased to $251.4 million or $1.73 per share compared to $242.6 million or $1.58 per share a year ago, beating the Zacks Consensus Estimate by 18 cents [2] - Quarterly net sales reached $1.04 billion, a 7% increase from $979.6 million in the prior year, driven by strong momentum in the Security and Compute verticals, surpassing the Zacks Consensus Estimate of $1.02 billion [3] Revenue Breakdown - Security Technology Group revenues were $551.9 million, up 11% from $498.7 million year-over-year, primarily due to demand for Guardicore Segmentation Solution and API security solutions [4] - Delivery segment revenues fell to $320 million from $329.4 million year-over-year, but exceeded the estimate of $301.6 million [5] - Compute segment revenues increased to $171.4 million from $151.5 million in the prior year, driven by demand for cloud infrastructure services, beating the estimate of $165.7 million [5] Regional Performance - Net sales from the United States were $527.6 million, a 4% year-over-year increase, while international revenues totaled $515.9 million, up from $470.8 million in the previous year [6] Operating Expenses and Margins - Total operating expenses rose to $892 million from $831.6 million year-over-year, while non-GAAP income from operations improved to $308.6 million from $281.5 million, with margins of 30% and 29% respectively [7] - Adjusted EBITDA increased to $444.4 million from $408.9 million in the prior year [7] Cash Flow and Share Repurchase - Akamai generated $459.1 million in cash from operating activities compared to $430.9 million in the prior year [8] - As of June 30, 2025, the company had $850.3 million in cash and cash equivalents and repurchased approximately 3.9 million shares for around $300 million [9] Future Outlook - For Q3 2025, Akamai expects revenues between $1.03 billion and $1.05 billion, with a non-GAAP operating margin projected at 28% [10] - For the full year 2025, revenues are expected to be in the range of $4.135 billion to $4.2 billion, with non-GAAP earnings projected between $6.60 and $6.80 per share [11]

Core Insights - Expedia Group (EXPE) reported second-quarter 2025 adjusted earnings of $4.24 per share, exceeding the Zacks Consensus Estimate by 2.42% and reflecting a year-over-year increase of 20.8% [1] - Revenues reached $3.79 billion, a 6.4% year-over-year rise, also surpassing the Zacks Consensus Estimate by 1.94% [1] - B2B revenues grew by 15% year over year to $1.21 billion, while B2C revenues increased by 2% to $2.48 billion [1] Gross Bookings - Total gross bookings amounted to $30.4 billion, marking a 5% year-over-year increase [2] - B2C gross bookings rose by 1%, while B2B gross bookings surged by 17%, achieving the 16th consecutive quarter of double-digit growth [2] - Lodging gross bookings increased by 6% year over year to $22.07 billion, with hotel bookings climbing by 8% [2] Operating Performance - Adjusted EBITDA for the quarter was $908 million, up 15.5% year over year, with an adjusted EBITDA margin of 24%, expanding by 190 basis points [3] - Direct sales and marketing expenses were $1.92 billion, representing 50.7% of revenues, an increase of 7.1% year over year [3] - Overhead expenses totaled $637 million, accounting for 16.8% of revenues, up 5.1% year over year [3] Profitability Metrics - Adjusted EBIT increased by 22.7% year over year to $583 million, with an adjusted EBIT margin improving by 200 basis points to 15.4% [4] Balance Sheet Overview - As of June 30, 2025, cash and cash equivalents and short-term investments were $6.7 billion, up from $6.1 billion as of March 31, 2025 [5] - Long-term debt stood at $4.466 billion, slightly up from $4.465 billion as of March 31, 2025 [5] - The gross leverage ratio was maintained at 2x, aligning with the target to uphold an investment-grade rating [5] Cash Flow - Net cash provided by operating activities was $1.12 billion for the quarter, with free cash flow amounting to $921 million [6] Future Guidance - For Q3 2025, EXPE expects gross bookings growth in the range of 5-7% and revenue growth between 4-6% [7] - The company anticipates adjusted EBITDA margins to increase by 50-100 basis points year over year for Q3 [9] - For the full year 2025, EXPE projects gross bookings and revenue growth in the 3-5% range, with adjusted EBITDA margin expansion of more than 100 basis points year over year [9]

Core Insights - Marathon Petroleum Corporation (MPC) reported second-quarter adjusted earnings per share of $3.96, exceeding the Zacks Consensus Estimate of $3.22, primarily due to an 11% year-over-year decline in costs and expenses [1] - However, the adjusted profit decreased from $4.12 in the previous year, mainly due to lower-than-expected contributions from the Midstream segment, which missed the consensus estimate by 1.8% [1] Financial Performance - MPC's revenues for the second quarter were $34.1 billion, surpassing the Zacks Consensus Estimate of $31 billion but reflecting an 11.1% year-over-year decline due to decreased sales and lower income from equity method investments [2] - The company declared a cash dividend of 91 cents per share, to be distributed on September 10, 2025, to shareholders on record as of August 20, 2025 [2] - In Q2, MPC distributed approximately $1 billion to shareholders and had $6 billion remaining under its authorized share repurchase programs as of June 30, 2025 [3] Segment Analysis - The Refining & Marketing segment reported adjusted EBITDA of $1.9 billion, down about 7% from $2 billion a year ago, attributed to higher planned turnaround costs and increased refining operating costs per barrel [4] - The refining margin increased to $17.58 per barrel, slightly up from $17.53 a year ago, and exceeded the consensus estimate by 13.9% [4] - Midstream segment adjusted EBITDA was $1.6 billion, up 1.3% from the previous year, driven by higher rates and throughputs from recent acquisitions, though partially offset by increased operating expenses [5] Expense and Capital Expenditure - Total expenses for the second quarter were $31.9 billion, down from $35.8 billion in the same quarter last year [6] - Capital expenditures amounted to $1.1 billion, with 32.6% allocated to Refining & Marketing and 64.9% to the Midstream segment, compared to $569 million in the prior year [6] Debt and Cash Position - As of June 30, 2025, MPC had cash and cash equivalents of $1.7 billion and total debt of $28.7 billion, resulting in a debt-to-capitalization ratio of 53.6% [7][9] Q3 Guidance - For Q3 2025, MPC anticipates refining operating costs of $5.70 per barrel and total refinery throughputs of 2,940 thousand barrels per day, with a utilization rate of 92% [10]

Financial Data and Key Metrics Changes - Revenue for Q2 2025 was $2,209 million, down 1.7% sequentially [5] - Gross margin decreased to 20.4%, down 2.1 percentage points sequentially [6] - EBITDA was $1,129 million with an EBITDA margin of 51.1% [6] - Profit attributable to the company was RMB 132 million [6] - Total assets at the end of Q2 were $49.4 billion, with total cash on hand of $13.1 billion [6] - Total liabilities were $16.7 billion, with total debt of $11.9 billion [6] - For the first half of 2025, revenue was $4,456 million, up 22% year over year [8] Business Line Data and Key Metrics Changes - Blended ASP decreased by 6.4% sequentially, while wafer shipments increased by 4.3% to 2,390 standard logic eight-inch equivalent wafers [10] - Revenue from automotive electronics shipments grew by 20% quarter over quarter, primarily from various types of automotive grade chips [12] - Revenue from eight-inch wafers achieved a 7% quarter over quarter growth [13] - Revenue from CIS increased over 20% sequentially [14] Market Data and Key Metrics Changes - Revenue distribution by region: China 84%, America 13%, and Eurasia 3%, with no significant changes quarter over quarter [11] - By application, wafer revenue from smartphones, computers and tablets, consumer electronics, connectivity and IoT, industrial, and automotive accounted for 25%, 15%, 41%, 8%, and 11% respectively [11] Company Strategy and Development Direction - The company aims to exceed industry average performance in the same market for the year [17] - Focus on deep collaborations with domestic customers to gain market share in analog chips [13] - The company is preparing for potential changes in demand due to tariff policies and market conditions [17] Management's Comments on Operating Environment and Future Outlook - Management expressed concerns about the potential impact of tariff policies and market stimulus on future demand [17] - Visibility for Q4 remains limited due to customer inventory buildup and potential slowdown in rush orders [16] - Confidence in continued demand despite external uncertainties [17] Other Important Information - Total capital expenditure for the first half of the year was $3,301 million [15] - Guidance for Q3 2025 indicates expected revenue growth of 5% to 7% sequentially, with gross margin anticipated to be in the range of 18% to 20% [8][16] Q&A Session Summary Question: What are the expectations for revenue growth in the upcoming quarters? - Management indicated that revenue is expected to increase by 5% to 7% sequentially in Q3 2025 [8] Question: How is the company addressing the challenges posed by tariff policies? - Management is actively collecting customer feedback and evaluating the impact of tariff policies on demand [17] Question: What is the outlook for automotive electronics shipments? - Automotive electronics shipments are expected to maintain steady growth, contributing significantly to revenue [12] Question: How does the company plan to manage inventory levels? - The company is working closely with customers to manage shipments and inventory levels effectively [10]

Core Insights - RLJ Lodging reported revenue of $363.1 million for the quarter ended June 2025, reflecting a year-over-year decline of 1.7% and a surprise of -0.64% compared to the Zacks Consensus Estimate of $365.45 million [1] - The company achieved an EPS of $0.48, which is an increase from $0.20 a year ago, resulting in an EPS surprise of +4.35% against the consensus estimate of $0.46 [1] - Over the past month, RLJ Lodging shares returned -3.8%, underperforming the Zacks S&P 500 composite's +1.2% change, and currently holds a Zacks Rank 4 (Sell) [3] Revenue Breakdown - Other revenue was reported at $25.07 million, slightly below the estimated $25.14 million, showing a year-over-year increase of +1.1% [4] - Food and beverage revenue reached $41.93 million, exceeding the average estimate of $40.88 million, with a year-over-year change of +2.7% [4] - Room revenue was $296.1 million, slightly below the average estimate of $297.35 million, representing a year-over-year decline of -2.5% [4] - Net Earnings Per Share (Diluted) was reported at $0.15, surpassing the average estimate of $0.12 [4]